We are live on ! Find out more
CABA icon

Cabaletta Bio

128 hedge funds and large institutions have $1.11B invested in Cabaletta Bio in 2023 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 41 increasing their positions, 31 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 10

78% more capital invested

Capital invested by funds: $623M → $1.11B (+$488M)

32% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 31

32% more funds holding

Funds holding: 97128 (+31)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

11.44% more ownership

Funds ownership: 102.75%114.18% (+11%)

27% less call options, than puts

Call options by funds: $6.37M | Put options by funds: $8.73M

Holders
128
Holders Change
+31
Holders Change %
+31.96%
% of All Funds
1.87%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
42
Increased
41
Reduced
31
Closed
10
Calls
$6.37M
Puts
$8.73M
Net Calls
-$2.37M
Net Calls Change
-$3.06M
Name Holding Trade Value Shares
Change
Change in
Stake
Victory Capital Management
26
Victory Capital Management
Texas
$9.17M +$5.67M +337,277 +506%
Alkeon Capital Management
27
Alkeon Capital Management
New York
$8.17M +$6.05M +360,000 New
Blackstone Inc
28
Blackstone Inc
New York
$7.89M +$5.84M +347,494 New
Northern Trust
29
Northern Trust
Illinois
$7.05M +$183K +10,903 +4%
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$6.46M +$4.79M +284,666 New
SSA
31
Schonfeld Strategic Advisors
New York
$5.71M +$4.23M +251,615 New
N
32
Nuveen
North Carolina
$5.49M +$1.78M +105,809 +78%
WP
33
Woodline Partners
California
$5.48M +$1.8M +107,269 +80%
Goldman Sachs
34
Goldman Sachs
New York
$5.41M -$1.04M -61,915 -21%
Voloridge Investment Management
35
Voloridge Investment Management
Florida
$5.37M +$3.79M +225,638 +2,097%
CCM
36
Cutter Capital Management
New York
$5.22M +$3.87M +230,000 New
IC
37
Ikarian Capital
Texas
$4.92M +$3.64M +216,620 New
Rafferty Asset Management
38
Rafferty Asset Management
New York
$4.75M +$1.53M +91,113 +77%
FTM
39
First Turn Management
California
$3.98M +$2.95M +175,359 New
Bank of America
40
Bank of America
North Carolina
$3.64M +$325K +19,334 +14%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$3.56M +$193K +11,486 +8%
GTC
42
Ghost Tree Capital
New York
$3.4M +$2.52M +150,000 New
UBS Group
43
UBS Group
Switzerland
$3.15M +$1.74M +103,662 +296%
Barclays
44
Barclays
United Kingdom
$2.93M +$1.08M +64,486 +100%
Ensign Peak Advisors
45
Ensign Peak Advisors
Utah
$2.68M +$1.98M +118,002 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$2.2M -$131K -7,807 -7%
Charles Schwab
47
Charles Schwab
California
$2.19M +$5.13K +305 +0.3%
TD Asset Management
48
TD Asset Management
Ontario, Canada
$2.13M +$1.57M +93,630 New
AllianceBernstein
49
AllianceBernstein
Tennessee
$2.12M -$1.21M -72,071 -44%
Jane Street
50
Jane Street
New York
$2.01M +$1.49M +88,409 New

CABA Hedge Fund Activity: Q4 2023 in Review

128 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q4 2023, worth a combined $1.11B — up 78% from $623M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new CABA positions and 10 closed out — a net gain of 32 holders — while 41 added to existing stakes and 31 trimmed.

The largest buyer was BlackRock, adding an estimated $33.1M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $43.8M sold.

  • 128 institutional investors held Cabaletta Bio (CABA) as of Q4 2023, up from 97 in Q3 2023.
  • Funds reported $1.11B of Cabaletta Bio stock for Q4 2023, up 78% quarter-over-quarter.
  • 42 funds opened new Cabaletta Bio positions in Q4 2023 and 10 closed out, a net change of +32 holders.
  • The largest Cabaletta Bio buyer in Q4 2023 was BlackRock, an estimated $33.1M added.
  • The largest Cabaletta Bio seller in Q4 2023 was Cormorant Asset Management, an estimated $43.8M sold.

Based on aggregated 13F filings for Q4 2023.